Back to News
Market Impact: 0.35
Stockholder Alert: Robbins LLP Informs Investors of the Hims & Hers Health, Inc. Class Action
Source: Business Wire
Legal & LitigationCybersecurity & Data PrivacyRegulation & Legislation
Hims (HIMS) faces a complaint alleging it shared customers’ protected health information with advertisers and used deceptive advertising practices. The allegations raise data-privacy and regulatory risk, which could pressure sentiment and potentially lead to enforcement or remediation costs.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
HIMS-0.90
More News
- Trump administration advances plan for peptide drugs favored by RFK Jr.
- Indonesia stocks suffer biggest daily slump since 1998 as MSCI weighs downgrade
- Taiwan to curb AI chip sales to China for more U.S. alignment- Bloomberg
- Supermicro promised a new CFO in December 2024. A $2.5 billion smuggling case and a co-founder’s arrest later, it has one
- Analysis-China’s super-rich scramble to exit offshore trusts, raise cash as taxman knocks
- Bank of America had to bring in 1,000 contractors to patch all the bugs Mythos identified